Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ZNTL
$1.53
-10.53%
Analyze
1M
-1.3%
3M
+4.1%
1Y
-45.9%
Market Cap:
$110.37M
Zentalis Pharmaceuticals Llc
Healthcare |
Biotechnology
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment of various cancers. The company is headquartered in New York, New York.
Click "Analyze" to generate stock analysis
ZNTL Price Trend and Signals
ZNTL Option Volumes & Open Interests (aggregated)
ZNTL Put Call Ratios and IV (aggregated)
ZNTL Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-22
Somewhat Bullish
macd_signal
Golden cross above zero detected.
2025-10-16
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-09
Somewhat Bullish
price_signal
Monthly high detected.